{
  "DOI": "10.1186/s40246-019-0241-3",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-019-0241-3",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\n\u003cjats:sec\u003e\n\u003cjats:title\u003eBackground\u003c/jats:title\u003e\n\u003cjats:p\u003eThe \u003cjats:underline\u003eh\u003c/jats:underline\u003eeat-\u003cjats:underline\u003es\u003c/jats:underline\u003ehock transcription \u003cjats:underline\u003ef\u003c/jats:underline\u003eactor 1 (HSF1) has been linked to cell proliferation and survival in cancer and has been proposed as a biomarker for poor prognosis. Here, we assessed the role of HSF1 expression in relation to copy number alteration (CNA) and cancer prognosis.\u003c/jats:p\u003e\n\u003c/jats:sec\u003e\n\u003cjats:sec\u003e\n\u003cjats:title\u003eMethods\u003c/jats:title\u003e\n\u003cjats:p\u003eUsing 10,287 cancer genomes from The Cancer Genome Atlas and Cbioportal databases, we assessed the association of HSF1 expression with CNA and cancer prognosis. CNA of 8q24.3 was categorized as diploid (reference), deletion (fewer copies), gain (+ 1 copy) and amplification (≥ + 2 copies). Multivariate logistic regression modeling was used to assess 5-year survival among those with a first cancer diagnosis and complete follow-up data (\u003cjats:italic\u003eN\u003c/jats:italic\u003e = 9568), categorized per anatomical location and histology, assessing interaction with tumor stage, and expressed as odds ratios and 95% confidence intervals.\u003c/jats:p\u003e\n\u003c/jats:sec\u003e\n\u003cjats:sec\u003e\n\u003cjats:title\u003eResults\u003c/jats:title\u003e\n\u003cjats:p\u003eWe found that only 54.1% of all tumors have a normal predicted 8q24.3 copy number and that 8q24.3 located genes including HSF1 are mainly overexpressed due to increased copies number of 8q24.3 in different cancers. The tumor of patients having respectively gain (+ 1 copy) and amplification (≥ + 2 copies) of 8q24.3 display a global increase of 5-year mortality (odds ratio = 1.98, 95% CI 1.22–3.21) and (OR = 2.19, 1.13–4.26) after full adjustment. For separate cancer types, tumor patients with 8q24.3 deletion showed a marked increase of 5-year mortality in uterine (OR = 4.84, [2.75–8.51]), colorectal (OR = 4.12, [1.15–14.82]), and ovarian (OR = 1.83, [1.39–2.41]) cancers; and decreased mortality in kidney cancer (OR = 0.41, [0.21–0.82]). Gain of 8q24.3 resulted in significant mortality changes in 5-year mortality for cancer of the uterus (OR = 3.67, [2.03–6.66]), lung (OR = 1.76, [1.24–2.51]), colorectal (OR = 1.75, [1.32–2.31]) cancers; and amplification for uterine (OR = 4.58, [1.43–14.65]), prostate (OR = 4.41 [3.41–5.71]), head and neck (OR = 2.68, [2.17–3.30]), and stomach (OR = 0.56, [0.36–0.87]) cancers.\u003c/jats:p\u003e\n\u003c/jats:sec\u003e\n\u003cjats:sec\u003e\n\u003cjats:title\u003eConclusions\u003c/jats:title\u003e\n\u003cjats:p\u003eHere, we show that CNAs of 8q24.3 genes, including HSF1, are tightly linked to 8q24.3 copy number in tumor patients and can affect patient outcome. Our results indicate that the integration of 8q24.3 CNA detection may be a useful predictor for cancer prognosis.\u003c/jats:p\u003e\n\u003c/jats:sec\u003e",
  "alternative-id": [
    "241"
  ],
  "article-number": "54",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "24 June 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "1 October 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "7 November 2019"
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "None."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Brusselaers",
      "given": "Nele",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Ekwall",
      "given": "Karl",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-8556-4459",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Durand-Dubief",
      "given": "Mickael",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2019,
        11,
        7
      ]
    ],
    "date-time": "2019-11-07T11:05:56Z",
    "timestamp": 1573124756000
  },
  "deposited": {
    "date-parts": [
      [
        2020,
        11,
        6
      ]
    ],
    "date-time": "2020-11-06T00:27:58Z",
    "timestamp": 1604622478000
  },
  "funder": [
    {
      "DOI": "10.13039/100000048",
      "award": [
        "CAN2015/169"
      ],
      "doi-asserted-by": "crossref",
      "name": "Cancer Society"
    },
    {
      "DOI": "10.13039/501100004359",
      "award": [
        "2016-01259"
      ],
      "doi-asserted-by": "crossref",
      "name": "Swedish Research Council"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        2,
        5
      ]
    ],
    "date-time": "2024-02-05T15:45:34Z",
    "timestamp": 1707147934413
  },
  "is-referenced-by-count": 13,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2019,
        11,
        7
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2019,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://creativecommons.org/licenses/by/4.0/",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            11,
            7
          ]
        ],
        "date-time": "2019-11-07T00:00:00Z",
        "timestamp": 1573084800000
      }
    },
    {
      "URL": "http://creativecommons.org/licenses/by/4.0/",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            11,
            7
          ]
        ],
        "date-time": "2019-11-07T00:00:00Z",
        "timestamp": 1573084800000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-019-0241-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1186/s40246-019-0241-3/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-019-0241-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2019,
        11,
        7
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2019,
        11,
        7
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2019,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1002/1878-0261.12108",
      "author": "L Malgerud",
      "doi-asserted-by": "publisher",
      "first-page": "1413",
      "issue": "10",
      "journal-title": "Mol Oncol",
      "key": "241_CR1",
      "unstructured": "Malgerud L, Lindberg J, Wirta V, Gustafsson-Liljefors M, Karimi M, Moro CF, Stecker K, Picker A, Huelsewig C, Stein M, et al. Bioinformatory-assisted analysis of next-generation sequencing data for precision medicine in pancreatic cancer. Mol Oncol. 2017;11(10):1413–29.",
      "volume": "11",
      "year": "2017"
    },
    {
      "DOI": "10.1371/journal.pone.0212801",
      "author": "C Franczak",
      "doi-asserted-by": "publisher",
      "first-page": "e0212801",
      "issue": "2",
      "journal-title": "PLoS One",
      "key": "241_CR2",
      "unstructured": "Franczak C, Dubouis L, Gilson P, Husson M, Rouyer M, Demange J, Leroux A, Merlin JL, Harle A. Integrated routine workflow using next-generation sequencing and a fully-automated platform for the detection of KRAS, NRAS and BRAF mutations in formalin-fixed paraffin embedded samples with poor DNA quality in patients with colorectal carcinoma. PLoS One. 2019;14(2):e0212801.",
      "volume": "14",
      "year": "2019"
    },
    {
      "DOI": "10.1200/PO.18.00183",
      "author": "AN Freedman",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "JCO Precision Oncol",
      "key": "241_CR3",
      "unstructured": "Freedman AN, Klabunde CN, Wiant K, Enewold L, Gray SW, Filipski KK, Keating NL, Leonard DGB, Lively T, McNeel TS, et al. Use of next-generation sequencing tests to guide cancer treatment: results from a nationally representative survey of oncologists in the United States. JCO Precision Oncol. 2018;2:1–13.",
      "volume": "2",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.ymgmr.2019.100464",
      "author": "P Hartman",
      "doi-asserted-by": "publisher",
      "first-page": "100464",
      "journal-title": "Mol Genet Metab Rep",
      "key": "241_CR4",
      "unstructured": "Hartman P, Beckman K, Silverstein K, Yohe S, Schomaker M, Henzler C, Onsongo G, Lam HC, Munro S, Daniel J, et al. Next generation sequencing for clinical diagnostics: five year experience of an academic laboratory. Mol Genet Metab Rep. 2019;19:100464.",
      "volume": "19",
      "year": "2019"
    },
    {
      "DOI": "10.1177/1758834009360519",
      "author": "S Mehta",
      "doi-asserted-by": "publisher",
      "first-page": "125",
      "issue": "2",
      "journal-title": "Ther Adv Med Oncol",
      "key": "241_CR5",
      "unstructured": "Mehta S, Shelling A, Muthukaruppan A, Lasham A, Blenkiron C, Laking G, Print C. Predictive and prognostic molecular markers for cancer medicine. Ther Adv Med Oncol. 2010;2(2):125–48.",
      "volume": "2",
      "year": "2010"
    },
    {
      "DOI": "10.1146/annurev-biochem-060809-095203",
      "author": "J Anckar",
      "doi-asserted-by": "publisher",
      "first-page": "1089",
      "journal-title": "Annu Rev Biochem",
      "key": "241_CR6",
      "unstructured": "Anckar J, Sistonen L. Regulation of HSF1 function in the heat stress response: implications in aging and disease. Annu Rev Biochem. 2011;80:1089–115.",
      "volume": "80",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s13277-015-3674-x",
      "author": "S Jiang",
      "doi-asserted-by": "publisher",
      "first-page": "4923",
      "issue": "7",
      "journal-title": "Tumour Biol",
      "key": "241_CR7",
      "unstructured": "Jiang S, Tu K, Fu Q, Schmitt DC, Zhou L, Lu N, Zhao Y. Multifaceted roles of HSF1 in cancer. Tumour Biol. 2015;36(7):4923–31.",
      "volume": "36",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.cell.2012.06.031",
      "author": "ML Mendillo",
      "doi-asserted-by": "publisher",
      "first-page": "549",
      "issue": "3",
      "journal-title": "Cell",
      "key": "241_CR8",
      "unstructured": "Mendillo ML, Santagata S, Koeva M, Bell GW, Hu R, Tamimi RM, Fraenkel E, Ince TA, Whitesell L, Lindquist S. HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers. Cell. 2012;150(3):549–62.",
      "volume": "150",
      "year": "2012"
    },
    {
      "DOI": "10.1073/pnas.1115031108",
      "author": "S Santagata",
      "doi-asserted-by": "publisher",
      "first-page": "18378",
      "issue": "45",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "241_CR9",
      "unstructured": "Santagata S, Hu R, Lin NU, Mendillo ML, Collins LC, Hankinson SE, Schnitt SJ, Whitesell L, Tamimi RM, Lindquist S, et al. High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer. Proc Natl Acad Sci U S A. 2011;108(45):18378–83.",
      "volume": "108",
      "year": "2011"
    },
    {
      "DOI": "10.1038/bjc.2014.262",
      "author": "H Engerud",
      "doi-asserted-by": "publisher",
      "first-page": "78",
      "issue": "1",
      "journal-title": "Br J Cancer",
      "key": "241_CR10",
      "unstructured": "Engerud H, Tangen IL, Berg A, Kusonmano K, Halle MK, Oyan AM, Kalland KH, Stefansson I, Trovik J, Salvesen HB, et al. High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors. Br J Cancer. 2014;111(1):78–84.",
      "volume": "111",
      "year": "2014"
    },
    {
      "DOI": "10.1186/s13046-017-0537-x",
      "author": "W Liang",
      "doi-asserted-by": "publisher",
      "first-page": "64",
      "issue": "1",
      "journal-title": "J Exp Clin Cancer Res",
      "key": "241_CR11",
      "unstructured": "Liang W, Liao Y, Zhang J, Huang Q, Luo W, Yu J, Gong J, Zhou Y, Li X, Tang B, et al. Heat shock factor 1 inhibits the mitochondrial apoptosis pathway by regulating second mitochondria-derived activator of caspase to promote pancreatic tumorigenesis. J Exp Clin Cancer Res. 2017;36(1):64.",
      "volume": "36",
      "year": "2017"
    },
    {
      "DOI": "10.2147/OTT.S153682",
      "author": "T Wan",
      "doi-asserted-by": "publisher",
      "first-page": "383",
      "journal-title": "OncoTargets Ther",
      "key": "241_CR12",
      "unstructured": "Wan T, Shao J, Hu B, Liu G, Luo P, Zhou Y. Prognostic role of HSF1 overexpression in solid tumors: a pooled analysis of 3,159 patients. OncoTargets Ther. 2018;11:383–93.",
      "volume": "11",
      "year": "2018"
    },
    {
      "DOI": "10.18632/oncotarget.25756",
      "author": "JK Bjork",
      "doi-asserted-by": "publisher",
      "first-page": "31200",
      "issue": "58",
      "journal-title": "Oncotarget",
      "key": "241_CR13",
      "unstructured": "Bjork JK, Ahonen I, Mirtti T, Erickson A, Rannikko A, Butzow A, Nordling S, Lundin J, Lundin M, Sistonen L, et al. Increased HSF1 expression predicts shorter disease-specific survival of prostate cancer patients following radical prostatectomy. Oncotarget. 2018;9(58):31200–13.",
      "volume": "9",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.cell.2009.02.024",
      "author": "J Luo",
      "doi-asserted-by": "publisher",
      "first-page": "823",
      "issue": "5",
      "journal-title": "Cell",
      "key": "241_CR14",
      "unstructured": "Luo J, Solimini NL, Elledge SJ. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell. 2009;136(5):823–37.",
      "volume": "136",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.cell.2012.11.043",
      "author": "YC Tang",
      "doi-asserted-by": "publisher",
      "first-page": "394",
      "issue": "3",
      "journal-title": "Cell",
      "key": "241_CR15",
      "unstructured": "Tang YC, Amon A. Gene copy-number alterations: a cost-benefit analysis. Cell. 2013;152(3):394–405.",
      "volume": "152",
      "year": "2013"
    },
    {
      "DOI": "10.1038/nrm2718",
      "author": "AJ Holland",
      "doi-asserted-by": "publisher",
      "first-page": "478",
      "issue": "7",
      "journal-title": "Nat Rev Mol Cell Biol",
      "key": "241_CR16",
      "unstructured": "Holland AJ, Cleveland DW. Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis. Nat Rev Mol Cell Biol. 2009;10(7):478–87.",
      "volume": "10",
      "year": "2009"
    },
    {
      "DOI": "10.4161/23723556.2014.976491",
      "author": "N Donnelly",
      "doi-asserted-by": "publisher",
      "first-page": "e976491",
      "issue": "2",
      "journal-title": "Mol Cell Oncol",
      "key": "241_CR17",
      "unstructured": "Donnelly N, Storchova Z. Aneuploidy and proteotoxic stress in cancer. Mol Cell Oncol. 2015;2(2):e976491.",
      "volume": "2",
      "year": "2015"
    },
    {
      "DOI": "10.1186/s40246-017-0131-5",
      "author": "CQ Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "35",
      "issue": "1",
      "journal-title": "Hum Genomics",
      "key": "241_CR18",
      "unstructured": "Zhang CQ, Williams H, Prince TL, Ho ES. Overexpressed HSF1 cancer signature genes cluster in human chromosome 8q. Hum Genomics. 2017;11(1):35.",
      "volume": "11",
      "year": "2017"
    },
    {
      "DOI": "10.1016/S1470-2045(17)30373-X",
      "author": "J Beane",
      "doi-asserted-by": "publisher",
      "first-page": "e494",
      "issue": "8",
      "journal-title": "Lancet Oncol",
      "key": "241_CR19",
      "unstructured": "Beane J, Campbell JD, Lel J, Vick J, Spira A. Genomic approaches to accelerate cancer interception. Lancet Oncol. 2017;18(8):e494–502.",
      "volume": "18",
      "year": "2017"
    },
    {
      "DOI": "10.1073/pnas.0705824104",
      "author": "JB Axelsen",
      "doi-asserted-by": "publisher",
      "first-page": "13122",
      "issue": "32",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "241_CR20",
      "unstructured": "Axelsen JB, Lotem J, Sachs L, Domany E. Genes overexpressed in different human solid cancers exhibit different tissue-specific expression profiles. Proc Natl Acad Sci U S A. 2007;104(32):13122–7.",
      "volume": "104",
      "year": "2007"
    },
    {
      "DOI": "10.1186/gm62",
      "author": "A Shlien",
      "doi-asserted-by": "publisher",
      "first-page": "62",
      "issue": "6",
      "journal-title": "Genome Med",
      "key": "241_CR21",
      "unstructured": "Shlien A, Malkin D. Copy number variations and cancer. Genome Med. 2009;1(6):62.",
      "volume": "1",
      "year": "2009"
    },
    {
      "DOI": "10.1097/CCO.0b013e328333dca4",
      "author": "A Shlien",
      "doi-asserted-by": "publisher",
      "first-page": "55",
      "issue": "1",
      "journal-title": "Curr Opin Oncol",
      "key": "241_CR22",
      "unstructured": "Shlien A, Malkin D. Copy number variations and cancer susceptibility. Curr Opin Oncol. 2010;22(1):55–63.",
      "volume": "22",
      "year": "2010"
    },
    {
      "DOI": "10.1016/S0092-8674(00)81683-9",
      "author": "D Hanahan",
      "doi-asserted-by": "publisher",
      "first-page": "57",
      "issue": "1",
      "journal-title": "Cell",
      "key": "241_CR23",
      "unstructured": "Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57–70.",
      "volume": "100",
      "year": "2000"
    },
    {
      "DOI": "10.1038/msb.2012.40",
      "author": "S Stingele",
      "doi-asserted-by": "publisher",
      "first-page": "608",
      "journal-title": "Mol Syst Biol",
      "key": "241_CR24",
      "unstructured": "Stingele S, Stoehr G, Peplowska K, Cox J, Mann M, Storchova Z. Global analysis of genome, transcriptome and proteome reveals the response to aneuploidy in human cells. Mol Syst Biol. 2012;8:608.",
      "volume": "8",
      "year": "2012"
    },
    {
      "DOI": "10.1126/scisignal.2004088",
      "author": "J Gao",
      "doi-asserted-by": "publisher",
      "first-page": "pl1",
      "issue": "269",
      "journal-title": "Sci Signal",
      "key": "241_CR25",
      "unstructured": "Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1.",
      "volume": "6",
      "year": "2013"
    },
    {
      "DOI": "10.1158/2159-8290.CD-12-0095",
      "author": "E Cerami",
      "doi-asserted-by": "publisher",
      "first-page": "401",
      "issue": "5",
      "journal-title": "Cancer Discov",
      "key": "241_CR26",
      "unstructured": "Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401–4.",
      "volume": "2",
      "year": "2012"
    },
    {
      "DOI": "10.1186/gb-2011-12-4-r41",
      "author": "CH Mermel",
      "doi-asserted-by": "publisher",
      "first-page": "R41",
      "issue": "4",
      "journal-title": "Genome Biol",
      "key": "241_CR27",
      "unstructured": "Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011;12(4):R41.",
      "volume": "12",
      "year": "2011"
    },
    {
      "DOI": "10.1093/nar/gkw1138",
      "author": "H Mi",
      "doi-asserted-by": "publisher",
      "first-page": "D183",
      "issue": "D1",
      "journal-title": "Nucleic Acids Res",
      "key": "241_CR28",
      "unstructured": "Mi H, Huang X, Muruganujan A, Tang H, Mills C, Kang D, Thomas PD. PANTHER version 11: expanded annotation data from gene ontology and Reactome pathways, and data analysis tool enhancements. Nucleic Acids Res. 2017;45(D1):D183–9.",
      "volume": "45",
      "year": "2017"
    },
    {
      "DOI": "10.1002/sim.7141",
      "author": "DL Burke",
      "doi-asserted-by": "publisher",
      "first-page": "855",
      "issue": "5",
      "journal-title": "Stat Med",
      "key": "241_CR29",
      "unstructured": "Burke DL, Ensor J, Riley RD. Meta-analysis using individual participant data: one-stage and two-stage approaches, and why they may differ. Stat Med. 2017;36(5):855–75.",
      "volume": "36",
      "year": "2017"
    },
    {
      "key": "241_CR30",
      "unstructured": "Fisher D. IPDMETAN: Stata module for performing two-stage IPD meta-analysis, Statistical Software Components S457785: Boston College Department of Economics, Revised 16 Sep 2017; 2014. \nhttps://econpapers.repec.org/software/bocbocode/s457785.htm\n\n."
    },
    {
      "DOI": "10.1002/sim.1186",
      "author": "JP Higgins",
      "doi-asserted-by": "publisher",
      "first-page": "1539",
      "issue": "11",
      "journal-title": "Stat Med",
      "key": "241_CR31",
      "unstructured": "Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.",
      "volume": "21",
      "year": "2002"
    },
    {
      "DOI": "10.1126/science.1238303",
      "author": "S Santagata",
      "doi-asserted-by": "publisher",
      "first-page": "1238303",
      "issue": "6143",
      "journal-title": "Science",
      "key": "241_CR32",
      "unstructured": "Santagata S, Mendillo ML, Tang YC, Subramanian A, Perley CC, Roche SP, Wong B, Narayan R, Kwon H, Koeva M, et al. Tight coordination of protein translation and HSF1 activation supports the anabolic malignant state. Science. 2013;341(6143):1238303.",
      "volume": "341",
      "year": "2013"
    },
    {
      "DOI": "10.1038/ng.2760",
      "author": "TI Zack",
      "doi-asserted-by": "publisher",
      "first-page": "1134",
      "issue": "10",
      "journal-title": "Nat Genet",
      "key": "241_CR33",
      "unstructured": "Zack TI, Schumacher SE, Carter SL, Cherniack AD, Saksena G, Tabak B, Lawrence MS, Zhsng CZ, Wala J, Mermel CH, et al. Pan-cancer patterns of somatic copy number alteration. Nat Genet. 2013;45(10):1134–40.",
      "volume": "45",
      "year": "2013"
    }
  ],
  "reference-count": 33,
  "references-count": 33,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-019-0241-3"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Copy number of 8q24.3 drives HSF1 expression and patient outcome in cancer: an individual patient data meta-analysis"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "13"
}